Old Web
Real world data: Trastuzumab w/o concurrent endocrine therapy in luminal HER2-positive metastatic breast cancer resulted in decreased overall survival
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI